Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2
Wen Chen, Liang Wen, Yingying Bao, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 52
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
SIRT1/SREBPs-mediated regulation of lipid metabolism
Shan Shen, Mingyang Shen, Lirun Kuang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107037-107037
Open Access | Times Cited: 38
Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
Yue Chen, Yadong Wang, Yawei Fu, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 11
Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer
Jing Yan, Di Chen, Zi Ye, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Closed Access | Times Cited: 10
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation
Jiyan Su, Xiaojie Lin, Dan Li, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Combination therapies for cancer: challenges and opportunities
Zhijun Zhou, Barish H. Edil, Min Li
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease
Shiman Jiang, Lvwan Xu, Yanfei Chen, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 6, pp. 1183-1198
Open Access | Times Cited: 6
Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms
Yijing Peng, Yizhe Ma, Zichen Luo, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 16
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality
Nicolas Guillot, Barnabé Roméo, Shima Sepehri Manesh, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 11, pp. 897-911
Open Access | Times Cited: 16
Abnormal tryptophan catabolism in diabetes mellitus and its complications: Opportunities and challenges
Jialiang Gao, Ting Yang, Bohan Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115395-115395
Open Access | Times Cited: 14
Multi-omics approaches for the understanding of therapeutic mechanism for Huang-Qi-Long-Dan Granule against ischemic stroke
Chuanhong Wu, Chaoyong Wu, Lixia Peng, et al.
Pharmacological Research (2024) Vol. 205, pp. 107229-107229
Open Access | Times Cited: 5
The potential of aryl hydrocarbon receptor as receptors for metabolic changes in tumors
Zhiying Wang, Yuanqi Zhang, Zhihong Liao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
The aryl hydrocarbon receptor as a tumor modulator: mechanisms to therapy
Kanita A. Chaudhry, Anna Bianchi
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Schisandra chinensis polysaccharide prevents alcohol-associated liver disease in mice by modulating the gut microbiota-tryptophan metabolism-AHR pathway axis
Yan-Yu Chi, Junyan Xiang, Huimin Li, et al.
International Journal of Biological Macromolecules (2024), pp. 136843-136843
Closed Access | Times Cited: 4
Disentangling the molecular mystery of tumour–microbiota interactions: Microbial metabolites
Y. Duan, Jia‐Hao Dai, Ying‐Qi Lu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 4
Community characteristics and relationship between gut microbiota and intratumoral microbiota in hepatocellular carcinoma
Hung-Wen Lin, Zhanshan Ma, Jin Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
Xuran Wang, Bin Zhang, Runqiu Jiang
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Application progress of early nutrition intervention in patients with hepatocellular carcinoma after liver transplantation
Shanshan Deng, Yuping Zhu, Zhitao Chen, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 3
Closed Access
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
Siqi Ren, Yinping Zhang, Xingyue Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Mechanisms of action of intestinal microorganisms and advances in head and neck tumors
Su Xialu, Ma Faqiang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A Mechanistic Study of the Feasibility of Ursodeoxycholic Acid in the Treatment of Colon Adenocarcinoma
Shuyu Liu, Mengyue Zhou, Xiaoli Huang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1839-1852
Open Access
Tas2r105 ameliorates gut inflammation, possibly through influencing the gut microbiota and metabolites
Xiucai Lan, Liang Ma, Jiaming Ma, et al.
mSystems (2025)
Open Access
The active ingredient β-sitosterol in the anti-inflammatory agents alleviates perianal inflammation in rats by inhibiting the expression of Srebf2, activating the PPAR signaling pathway, and altering the composition of gut microbiota
Yanlan Wu, Hao Ge, Haoran Zhao, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114470-114470
Closed Access
4-acetamidobutanoic acid, a γ-aminobutyric acid derivative, inhibits Streptococcus mutans growth, adhesion, and biofilm formation
Shanshan Liu, L. Ding, Zhenzhen Li, et al.
Chemical Engineering Journal (2025), pp. 162426-162426
Closed Access
Page 1 - Next Page

Scroll to top